Royal Sense Ltd vs Samsrita Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Royal Sense Ltd is ₹ 69.95 as of 22 Oct 15:30 . The P/E Ratio of Royal Sense Ltd changed from 34 on March 2024 to 9.4 on March 2026 . This represents a CAGR of -34.85% over 3 yearsThe P/E Ratio of Samsrita Labs Ltd changed from 28.5 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 years The Market Cap of Royal Sense Ltd changed from ₹ 53.9 crore on March 2024 to ₹ 66.88 crore on March 2026 . This represents a CAGR of 7.46% over 3 yearsThe Market Cap of Samsrita Labs Ltd changed from ₹ 64.64 crore on March 2021 to ₹ 36.08 crore on March 2026 . This represents a CAGR of -9.26% over 6 years The revenue of Royal Sense Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Samsrita Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0.05 crore. This represent the decline of -100% The ebitda of Royal Sense Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Samsrita Labs Ltd for the Jun '26 is ₹ -0.31 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the growth of 158.33% The net profit of Royal Sense Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Samsrita Labs Ltd changed from ₹ -0.28 crore to ₹ -0.31 crore over 5 quarters. This represents a CAGR of 8.48% The Dividend Payout of Royal Sense Ltd changed from 0 % on March 2021 to 0 % on September 2023 . This represents a CAGR of 0.0% over 8 yearsThe Dividend Payout of Samsrita Labs Ltd changed from 0 % on March 2021 to 0 % on September 2023 . This represents a CAGR of 0.0% over 8 years .

About Royal Sense Ltd

Royal Sense Limited was incorporated as a Public Limited Company pursuant to a Certificate of Incorporation dated April 06, 2023, issued by the Registrar of Companies, Central Registration Centre.
Prior to the incorporation of Company, the Promoter Rishabh Arora was running the business in sole proprietorships under the name 'M/s Royal Traders, M/s PHT & M/s Anaya'. In 2015, the Company started their business under proprietorship as M/s Royal Traders; in 2018 as M/s PHT and proprietorship as M/s Anaya in 2020.
Later on, April 28, 2023, the running business of the aforesaid proprietorship concern was acquired by the Company, along with the assets and liabilities of the proprietorship concern as going concern.
The Company has absorbed the business line & distribution network of firms. 'RoyalSense' is the suppliers of high quality goods that meet international standards required for hospitals, laboratories, institutions and clinics to provide health services.

About Samsrita Labs Ltd

Samsrita Labs Limited was initially established as 'Dr Habeebullah Life Sciences Limited' on January 25, 1996.
The name of the Company was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022.
Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and R&D in New Drug Discovery but due to other reasons, aimed to shifting into Bio-pharma activities like Trading, Exports & Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, R&D etc through joint ventures or associations or mergers or by its own.
The Company is engaged into the business of research & experimental development on natural sciences and engineering, including bio pharma and hospital services also. In 2017, the Company changed its Main Objects clauses by venturing into the business of Bio-Pharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME - Pro Drug); Clinical Research Organization (CRO) related activities; Stem Cell - Lab, Research and Therapy; Research and Development in Bio-technology; Consultancy Division and Pharmacy; Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc.

FAQs for the comparison of Royal Sense Ltd and Samsrita Labs Ltd

Which company has a larger market capitalization, Royal Sense Ltd or Samsrita Labs Ltd?

Market cap of Royal Sense Ltd is 37 Cr while Market cap of Samsrita Labs Ltd is 30 Cr

What are the key factors driving the stock performance of Royal Sense Ltd and Samsrita Labs Ltd?

The stock performance of Royal Sense Ltd and Samsrita Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Royal Sense Ltd and Samsrita Labs Ltd?

As of October 25, 2026, the Royal Sense Ltd stock price is INR ₹69.95. On the other hand, Samsrita Labs Ltd stock price is INR ₹13.42.

How do dividend payouts of Royal Sense Ltd and Samsrita Labs Ltd compare?

To compare the dividend payouts of Royal Sense Ltd and Samsrita Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.